CPB2-AS1

Across TCGA pan-cancer cohorts, CPB2-AS1 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated CPB2-AS1 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher CPB2-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated CPB2-AS1 expression acts as an unfavorable survival marker, although some lineages such as UCS and UVM show a favorable association.

UCS, UVM, and COAD are the cancer types where CPB2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Quartile	All	0.800	0.199	<.001	82	view →
UVM	OS	Median	All	0.727	0.382	.005	43	view →
COAD	DFS	Tertile	All	0.732	0.868	<.001	30	view →
BLCA	DFS	Median	All	0.269	0.422	.005	26	view →
LGG	DFS	Tertile	All	0.520	0.320	.001	26	view →
LIHC	OS	Tertile	III,IV	0.807	0.460	<.001	24	view →
KIRC	DFS	Median	IV	0.453	0.223	.002	21	view →
MESO	OS	Tertile	All	0.592	0.201	.011	21	view →
LUSC	OS	Median	III,IV	0.165	0.779	.001	12	view →
ACC	OS	Tertile	IV	0.344	0.724	.038	12	view →
KIRP	DFS	Quartile	All	1.000	0.667	.035	10	view →
CHOL	DFS	Quartile	II,III,IV	0.238	0.689	.021	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

CPB2-AS1–UCS (OS)

Open the UCS breakdown →